• 1
    Galmiche JP, Janssens J. The pathophysiology of gastro-oesophageal reflux disease: an overview. Gut 1995; 30(Suppl. 211): 718.
  • 2
    Holloway RH, Dent J. Pathophysiology of gastroesophageal reflux. Lower esophageal sphincter dysfunction in gastroesophageal reflux disease. Gastroenterol Clin N Am 1990; 19: 51725.
  • 3
    Penagini R, Schoeman MN, Dent J, Tippett MD, Holloway RH. Motor events underlying gastro-oesophageal reflux in ambulant patients with reflux oesophagitis. Neurogastroenterol Motil 1996; 8: 13141.
  • 4
    Van Herwaarden MA, Samsom M, Smout AJPM. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxation. Gastroenterology 2000; 119: 143946.
  • 5
    Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology 2000; 118: 68895.
  • 6
    Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management: The Genval Workshop Report. Gut 1999; 44(Suppl. 2): S116.
  • 7
    Sifrim D, Holloway R, Silny J, et al. Acid, non-acid, and gas reflux in patients with gastroesophageal reflux during ambulatory 24-hour pH-impedence recordings. Gastroenterology 2001; 120: 158898.
  • 8
    Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001; 120: 1599606.
  • 9
    Koek GH, Tack J, Sifrim D, Lerut T, Janssens J. The role of acid in duodenal gastroesophageal reflux in symptomatic GERD. Am J Gastroenterol 2001; 96: 203340.
    Direct Link:
  • 10
    Quigley EMM, DiBaise JK. Non-erosive reflux disease: the real problem in gastro-oesophageal reflux disease. Digest Liver Dis 2001; 33: 5237.
  • 11
    Fass R, Fennerty B, Vakil N. Non-erosive reflux disease current concepts and dilemmas. Am J Gastroenterol 2001; 96: 30314.
  • 12
    Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA. Functional gastrointestinal disorders. Gut 1999; 24(Suppl. II): 16.
  • 13
    Tew S, Jamieson GG, Pilowsky I, Myers J. The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis. Dis Esophagus 1997; 10: 915.
  • 14
    Galmiche JP, Barthelmy P, Hamelin B. Treating the symptoms of gastroesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997; 11: 76573.
  • 15
    Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 9749.
  • 16
    Bate CM, Griffin SM, Keeling PW, et al. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 1996; 10: 54755.
  • 17
    Richter JE, Kovacs TO, Greski-Rose PA, Huang B, Fisher R. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther 1999; 13: 795804.
  • 18
    Weusten BL, Akkermans LM, VanBerge-Henegouwen GP, Smout AJ. Dynamic characteristics of gastro-oesophageal reflux in ambulatory patients with gastro-oesophageal reflux disease and normal control subjects. Scand J Gastroenterol 1995; 30: 7317.
  • 19
    Shaker R, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 1995; 109: 157582.
  • 20
    Smout AJ, Breedijk M, Van Der Zouw C, Akkermans LM. Physiological gastroesophageal reflux and esophageal motor activity studied with a new system for 24-hour recording and automated analysis. Dig Dis Sci 1989; 34: 3728.
  • 21
    Lam HG, Breumelhof R, Roelofs JM, VanBerge-Henegouwen GP, Smout AJ. What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci 1994; 39: 4029.
  • 22
    Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 35861.
  • 23
    Weusten BL, Roelofs JM, Akkermans LM, VanBerge-Henegouwen GP, Smout AJ. The symptom association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 17415.
  • 24
    Hosmer DW, Lemeshow S. In:John Wiley and Sons, Inc, ed. Applied Logistic Regression, 2nd edn. New York: Wiley Series, Wiley-Interscience Publication, 2000.
  • 25
    Johnston BT, Lewis SA, Collins JS, McFarland RJ, Love AH. Acid perception in gastro-oesophageal reflux disease is dependent on psychosocial factors. Scand J Gastroenterol 1995; 30: 15.
  • 26
    Watson RGP, Tham TCK, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux. The ‘sensitive oesophagus’. Gut 1997; 40: 58790.
  • 27
    Quigley EMM. Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003; 98(Suppl. 3): 2430.
  • 28
    Stanciu C, Bennett JR. Oesophageal acid clearing: one factor in the production of reflux oesophagitis. Gut 1974; 15: 8527.
  • 29
    Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD) — acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 53745.
  • 30
    Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995; 37: 712.
  • 31
    Marrero JM, Caestecker JS, Maxwell JD. Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease. Gut 1994; 35: 44757.
  • 32
    Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 45764.
  • 33
    Weusten BL, Akkermans LM, VanBerge-Henegouwen GP, Smout AJ. Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics. Gastroenterology 1995; 108: 173944.
  • 34
    Howard PJ, Maher L, Pryde A, Heading RC. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut 1991; 32: 12832.
  • 35
    Niemantsverdriet EC, Timmer R, Breumelhof R. Segmental acid sensitivity of the esophagus in patients with endoscopy-negative GERD. Gastroenterology 1997; 112: A237(Abstract).
  • 36
    Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 136373.
  • 37
    Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG. Contribution of central sensitisation to the development of non-cardiac chest-pain. Lancet 2000; 356: 11549.
  • 38
    Penagini R, Heobard G, Horowitz M, et al. Motor function of the proximal stomach and visceral perception in gastro-oesophageal reflux disease. Gut 1998; 42: 2517.
  • 39
    Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 125968.
  • 40
    DiBiase JK, Lof J, Akromis I, Quigley EMM. An open-label comparison of omeprazole and cisapride in endoscopy negative reflux disease. Am J Gastroenterol 1999; 94: A2583(Abstract).
  • 41
    Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 134652.
  • 42
    Quigley EMM. Motility, heartburn and dyspepsia. Aliment Pharmacol Ther 1997; 11(Suppl. 2): 4150.
  • 43
    Takeda T, Liu J, Mittal R. Heartburn and chest pain correlate with sustained esophageal contractions: analysis of large number of symptoms. Gastroenterology 2002; 122: A359(Abstract).